Our European Expansion Continues
After successfully launching in Slovenia in mid-2025, Gene Matrix AI has rapidly expanded across Southeast Europe. Our newest operations in Serbia, Bosnia and Herzegovina, North Macedonia, and Azerbaijan mark a significant milestone in our mission to make precision medicine accessible globally.
Why the Balkans?
Southeast Europe has a growing demand for advanced medical diagnostics but limited access to cutting-edge genomic testing. By establishing local partnerships and laboratory infrastructure, we’re bringing world-class genetic testing closer to millions of patients who previously had to travel abroad for such services.
Local Partnerships and Infrastructure
In each country, we’ve partnered with:
- Leading hospitals and clinics — for sample collection and clinical integration
- Local laboratories — for initial processing and logistics
- Medical universities — for clinician training and research collaboration
- Health ministries — for regulatory compliance and reimbursement pathways
Services Available in the Balkans
Patients in Serbia, Bosnia, North Macedonia, and Azerbaijan now have access to our full suite of genetic tests:
- GeneCancer™ — 108-gene hereditary cancer panel
- GenePGx™ — 700+ medication pharmacogenomics test
- GeneCore™ — comprehensive whole-exome analysis
- GeneHealth™ — wellness and longevity genetic screening
Training the Next Generation of Genomic Clinicians
Through our Gene Matrix Academy program, we’re training local healthcare providers on interpreting genetic test results and integrating precision medicine into their clinical practice. Over 200 physicians have already completed our certification program.
Looking Ahead
Our Balkan expansion is just the beginning. We plan to launch in Croatia, Montenegro, Albania, and Bulgaria by Q3 2026, creating a comprehensive precision medicine network across Southeast Europe.
